Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunosuppressive Drugs and COVID-19: A Review
Tessa S. Schoot, Angèle P. M. Kerckhoffs, Luuk B. Hilbrands, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 113

Showing 1-25 of 113 citing articles:

COVID-19 and Myositis: What We Know So Far
Ahmad Saud, R Naveen, Rohit Aggarwal, et al.
Current Rheumatology Reports (2021) Vol. 23, Iss. 8
Open Access | Times Cited: 136
The autonomic aspects of the post-COVID19 syndrome
Arad Dotan, Paula David, Dana Arnheim, et al.
Autoimmunity Reviews (2022) Vol. 21, Iss. 5, pp. 103071-103071
Open Access | Times Cited: 109
Parallels in Sepsis and COVID-19 Conditions: Implications for Managing Severe COVID-19
Charles Ochieng’ Olwal, Nora Nghochuzie Nganyewo, Kesego Tapela, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 87
Clinical practice guidelines in multisystem inflammatory syndrome (MIS-C) related to COVID-19: a critical review and recommendations
Alanood S. Algarni, Njoud M. Alamri, Noor Z. Khayat, et al.
World Journal of Pediatrics (2022) Vol. 18, Iss. 2, pp. 83-90
Open Access | Times Cited: 43
Therapeutic bacteria and viruses to combat cancer: double-edged sword in cancer therapy: new insights for future
Aref Yarahmadi, M. Amin Zare, Masoomeh Aghayari, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 13
SARS-CoV-2-specific serological and functional T cell immune responses during acute and early COVID-19 convalescence in solid organ transplant patients
Alexandre Favà, Laura Donadeu, Núria Sabé, et al.
American Journal of Transplantation (2021) Vol. 21, Iss. 8, pp. 2749-2761
Open Access | Times Cited: 54
Identification of host transcriptome-guided repurposable drugs for SARS-CoV-1 infections and their validation with SARS-CoV-2 infections by using the integrated bioinformatics approaches
Fee Faysal Ahmed, Md. Selim Reza, Md. Shahin Sarker, et al.
PLoS ONE (2022) Vol. 17, Iss. 4, pp. e0266124-e0266124
Open Access | Times Cited: 29
Immunosuppression and SARS-CoV-2 Infection in Kidney Transplant Recipients
Arnaud Devresse, Julien De Greef, Jean Cyr Yombi, et al.
Transplantation Direct (2022) Vol. 8, Iss. 3, pp. e1292-e1292
Open Access | Times Cited: 29
Emerging viral infections in immunocompromised patients: A great challenge to better define the role of immune response
Chiara Agrati, Barbara Bartolini, Veronica Bordoni, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 22
SARS-CoV-2 proteins and anti-COVID-19 drugs induce lytic reactivation of an oncogenic virus
Jungang Chen, Lu Dai, Lindsey Barrett, et al.
Communications Biology (2021) Vol. 4, Iss. 1
Open Access | Times Cited: 39
Hematopoietic stem cell transplantation for autoimmune diseases in the time of COVID-19: EBMT guidelines and recommendations
Raffaella Greco, Tobias Alexander, Joachim Burman, et al.
Bone Marrow Transplantation (2021) Vol. 56, Iss. 7, pp. 1493-1508
Open Access | Times Cited: 39
Development of humoral and cellular immunological memory against SARS-CoV-2 despite B cell depleting treatment in multiple sclerosis
Klara Asplund Högelin, Nicolas Ruffin, Elisa Pin, et al.
iScience (2021) Vol. 24, Iss. 9, pp. 103078-103078
Open Access | Times Cited: 39
COVID-19 and Fungal infections: a double debacle
Sara Mina, Hajar Yaakoub, Cédric Annweiler, et al.
Microbes and Infection (2022) Vol. 24, Iss. 8, pp. 105039-105039
Open Access | Times Cited: 24
COVID-19 Mortality in Vaccinated vs. Unvaccinated Liver & Kidney Transplant Recipients: A Single-Center United States Propensity Score Matching Study on Historical Data
Hailey Hardgrave, Allison Wells, Joseph Nigh, et al.
Vaccines (2022) Vol. 10, Iss. 11, pp. 1921-1921
Open Access | Times Cited: 23
The AI-Assisted Identification and Clinical Efficacy of Baricitinib in the Treatment of COVID-19
Peter J. Richardson, Bruce Robinson, Daniel P. Smith, et al.
Vaccines (2022) Vol. 10, Iss. 6, pp. 951-951
Open Access | Times Cited: 20
Phage-Derived Depolymerase: Its Possible Role for Secondary Bacterial Infections in COVID-19 Patients
Amina Nazir, Jiaoyang Song, Yibao Chen, et al.
Microorganisms (2023) Vol. 11, Iss. 2, pp. 424-424
Open Access | Times Cited: 11
COVID-19-associated-mucormycosis: possible role of free iron uptake and immunosuppression
Tahani Tabassum, Yusha Araf, Abu Tayab Moin, et al.
Molecular Biology Reports (2021) Vol. 49, Iss. 1, pp. 747-754
Open Access | Times Cited: 26
Risk of COVID-19 infection, hospitalization, and mortality in patients with psoriasis treated by interleukin-17 inhibitors
Khalaf Kridin, Yochai Schonmann, A Solomon, et al.
Journal of Dermatological Treatment (2021) Vol. 33, Iss. 4, pp. 2014-2020
Open Access | Times Cited: 24
The Cytokine Storm in COVID-19: The Strongest Link to Morbidity and Mortality in the Current Epidemic
Maamoun Basheer, Elias Saad, Nimer Assy
COVID (2022) Vol. 2, Iss. 5, pp. 540-552
Open Access | Times Cited: 19
Correlation between Type I Interferon Associated Factors and COVID-19 Severity
Dóra Bencze, Tünde Fekete, Kitti Pázmándi
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10968-10968
Open Access | Times Cited: 18
Outcomes and risk factors of COVID-19 in patients with bullous pemphigoid: a cross-sectional study
Yuexin Zhang, Dawei Huang, Yuling Shi, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
The DESTINIES Study: an online Delphi study to build international consensus on the medical conditions and procedures that confer immunosuppression and their respective COVID-19 risk profiles
Meredith Leston, José M. Ordóñez‐Mena, Mark Joy, et al.
EClinicalMedicine (2025) Vol. 83, pp. 103239-103239
Open Access
Challenges and Opportunities from Targeting Inflammatory Responses to SARS-CoV-2 Infection: A Narrative Review
Vincenzo Lariccia, Simona Magi, Tiziano Serfilippi, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 12, pp. 4021-4021
Open Access | Times Cited: 26
Risk of COVID-19 and its complications in patients with atopic dermatitis undergoing dupilumab treatment—a population-based cohort study
Khalaf Kridin, Yochai Schonmann, A Solomon, et al.
Immunologic Research (2021) Vol. 70, Iss. 1, pp. 106-113
Open Access | Times Cited: 22
The risk of COVID-19 in patients with bullous pemphigoid and pemphigus: A population-based cohort study
Khalaf Kridin, Yochai Schonmann, Orly Weinstein, et al.
Journal of the American Academy of Dermatology (2021) Vol. 85, Iss. 1, pp. 79-87
Open Access | Times Cited: 20
Page 1 - Next Page

Scroll to top